• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec5
Xenon Pharmaceuticals Announces 48-Month Study Results for Azetukalner in Refractory Epilepsy
14:00
Nov25
Xenon Pharmaceuticals to Present New Clinical Data on Azetukalner at AES 2025
13:30
Nov6
Wedbush Analyst Cuts Xenon Pharmaceuticals FY2029 EPS Estimate
14:17
Nov5
Xenon Pharmaceuticals Highlights Optimism from Clinical Progress and Financial Status
00:57
Nov4
Gerberry Recommends Healthcare Stocks; H.C. Wainwright Reiterates Xenon Buy Rating
15:08
Xenon Pharma released FY2025 9 Months Earnings on November 3 After-Market EST, Actual Revenue: USD 7.5 M, Actual EPS: USD -3.0495
00:00

Schedules & Filings

Schedules
Filings
Nov3
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -90.9 M, EPS -1.1469

Aug11
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -84.71 M, EPS -1.0728

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.5 M, Net Income -65.05 M, EPS -0.8266

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
GURE
8.190
+72.78%
+3.450
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
View More